Literature DB >> 23993337

Iron deficiency modifies gene expression variation induced by augmented hypoxia sensing.

Joe G N Garcia1,2, Roberto F Machado1,2, Victor R Gordeuk3, Xu Zhang3, Wei Zhang4,5, Shwu-Fan Ma6, Galina Miasniakova7, Adelina Sergueeva8, Tatiana Ammosova9, Min Xu9, Sergei Nekhai9, Mehdi Nourai9, Michael S Wade1,2, Josef T Prchal10.   

Abstract

In congenital Chuvash polycythemia (CP), VHL(R200W) homozygosity leads to elevated hypoxia inducible factor (HIF) levels at normoxia. CP is often treated by phlebotomy resulting in iron deficiency, permitting us to examine the separate and synergistic effects of iron deficiency and HIF signaling on gene expression. We compared peripheral blood mononuclear cell gene expression profiles of eight VHL(R200W) homozygotes with 17 wildtype individuals with normal iron status and found 812 up-regulated and 2120 down-regulated genes at false discovery rate of 0.05. Among differential genes we identified three major gene regulation modules involving induction of innate immune responses, alteration of carbohydrate and lipid metabolism, and down-regulation of cell proliferation, stress-induced apoptosis and T-cell activation. These observations suggest molecular mechanisms for previous observations in CP of lower blood sugar without increased insulin and low oncogenic potential. Studies including 16 additional VHL(R200W) homozygotes with low ferritin indicated that iron deficiency enhanced the induction effect of VHL(R200W) for 50 genes including hemoglobin synthesis loci but suppressed the effect for 107 genes enriched for HIF-2 targets. This pattern is consistent with potentiation of HIF-1α protein stability by iron deficiency but a trend for down-regulation of HIF-2α translation by iron deficiency overriding an increase in HIF-2α protein stability.
© 2013.

Entities:  

Keywords:  Chuvash polycythemia; Gene expression; Hypoxia inducible factor; Hypoxia-sensing; Iron deficiency; VHL

Mesh:

Substances:

Year:  2013        PMID: 23993337      PMCID: PMC3852195          DOI: 10.1016/j.bcmd.2013.07.016

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  57 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  Using gene-network landscape to dissect genotype effects of TCF7L2 genetic variant on diabetes and cardiovascular risk.

Authors:  Andre R Vaquero; Noely E Ferreira; Samantha V Omae; Mariliza V Rodrigues; Samantha K Teixeira; Jose E Krieger; Alexandre C Pereira
Journal:  Physiol Genomics       Date:  2012-08-07       Impact factor: 3.107

3.  Hemoglobin induction in mouse macrophages.

Authors:  L Liu; M Zeng; J S Stamler
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

4.  Inducible expression of BNIP3 provokes mitochondrial defects and hypoxia-mediated cell death of ventricular myocytes.

Authors:  Kelly M Regula; Karen Ens; Lorrie A Kirshenbaum
Journal:  Circ Res       Date:  2002-08-09       Impact factor: 17.367

5.  HIF2alpha inhibition promotes p53 pathway activity, tumor cell death, and radiation responses.

Authors:  Jessica A Bertout; Amar J Majmundar; John D Gordan; Jennifer C Lam; Dara Ditsworth; Brian Keith; Eric J Brown; Katherine L Nathanson; M Celeste Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-12       Impact factor: 11.205

6.  Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha.

Authors:  Denise A Chan; Patrick D Sutphin; Nicholas C Denko; Amato J Giaccia
Journal:  J Biol Chem       Date:  2002-08-16       Impact factor: 5.157

7.  Altered cytokine profiles in patients with Chuvash polycythemia.

Authors:  Xiaomei Niu; Galina Y Miasnikova; Adelina I Sergueeva; Lydia A Polyakova; Daniel J Okhotin; Nikolai V Tuktanov; Mehdi Nouraie; Tatiana Ammosova; Sergei Nekhai; Victor R Gordeuk
Journal:  Am J Hematol       Date:  2009-02       Impact factor: 10.047

Review 8.  Emerging concepts in acute mountain sickness and high-altitude cerebral edema: from the molecular to the morphological.

Authors:  Damian Miles Bailey; Peter Bärtsch; Michael Knauth; Ralf W Baumgartner
Journal:  Cell Mol Life Sci       Date:  2009-09-10       Impact factor: 9.261

9.  Integrating microarray analysis and the soybean genome to understand the soybeans iron deficiency response.

Authors:  Jamie A O'Rourke; Rex T Nelson; David Grant; Jeremy Schmutz; Jane Grimwood; Steven Cannon; Carroll P Vance; Michelle A Graham; Randy C Shoemaker
Journal:  BMC Genomics       Date:  2009-08-13       Impact factor: 3.969

10.  Therapeutic potential of retinoid x receptor modulators for the treatment of the metabolic syndrome.

Authors:  Jane A Pinaire; Anne Reifel-Miller
Journal:  PPAR Res       Date:  2007-03-28       Impact factor: 4.964

View more
  12 in total

1.  Prospective study of thrombosis and thrombospondin-1 expression in Chuvash polycythemia.

Authors:  Adelina Sergueeva; Galina Miasnikova; Binal N Shah; Jihyun Song; Ekaterina Lisina; Daniel J Okhotin; Mehdi Nouraie; Sergei Nekhai; Tatiana Ammosova; Xiao Mei Niu; Josef T Prchal; Xu Zhang; Victor R Gordeuk
Journal:  Haematologica       Date:  2017-01-19       Impact factor: 9.941

2.  Genetic polymorphism of APOB is associated with diabetes mellitus in sickle cell disease.

Authors:  Xu Zhang; Wei Zhang; Santosh L Saraf; Mehdi Nouraie; Jin Han; Michel Gowhari; Johara Hassan; Galina Miasnikova; Adelina Sergueeva; Sergei Nekhai; Rick Kittles; Roberto F Machado; Joe G N Garcia; Mark T Gladwin; Martin H Steinberg; Paola Sebastiani; Donald A McClain; Victor R Gordeuk
Journal:  Hum Genet       Date:  2015-05-30       Impact factor: 4.132

3.  A genetic variation associated with plasma erythropoietin and a non-coding transcript of PRKAR1A in sickle cell disease.

Authors:  Xu Zhang; Binal N Shah; Wei Zhang; Santosh L Saraf; Galina Miasnikova; Adelina Sergueeva; Tatiana Ammosova; Xiaomei Niu; Mehdi Nouraie; Sergei Nekhai; Oswaldo Castro; Mark T Gladwin; Josef T Prchal; Joe G N Garcia; Roberto F Machado; Victor R Gordeuk
Journal:  Hum Mol Genet       Date:  2016-10-15       Impact factor: 6.150

4.  Peripheral blood mononuclear cells show prominent gene expression by erythroid progenitors in diseases characterized by heightened erythropoiesis.

Authors:  Xu Zhang; Jihyun Song; Binal N Shah; Sergei Nekhai; Galina Miasnikova; Adelina Sergueeva; Josef T Prchal; Victor R Gordeuk
Journal:  Br J Haematol       Date:  2020-05-12       Impact factor: 6.998

5.  Thrombotic risk in congenital erythrocytosis due to up-regulated hypoxia sensing is not associated with elevated hematocrit.

Authors:  Victor R Gordeuk; Galina Y Miasnikova; Adelina I Sergueeva; Felipe R Lorenzo; Xu Zhang; Jihyun Song; David W Stockton; Josef T Prchal
Journal:  Haematologica       Date:  2019-07-09       Impact factor: 9.941

Review 6.  Iron, oxygen, and the pulmonary circulation.

Authors:  Matthew C Frise; Peter A Robbins
Journal:  J Appl Physiol (1985)       Date:  2015-06-11

Review 7.  Re-evaluation of hematocrit as a determinant of thrombotic risk in erythrocytosis.

Authors:  Victor R Gordeuk; Nigel S Key; Josef T Prchal
Journal:  Haematologica       Date:  2019-03-14       Impact factor: 9.941

8.  Maternal Iron Deficiency Modulates Placental Transcriptome and Proteome in Mid-Gestation of Mouse Pregnancy.

Authors:  Chang Cao; Miguel A Prado; Liang Sun; Shira Rockowitz; Piotr Sliz; Joao A Paulo; Daniel Finley; Mark D Fleming
Journal:  J Nutr       Date:  2021-05-11       Impact factor: 4.798

9.  Iron deficiency is a possible risk factor causing right heart failure in Tibetan children living in high altitude area.

Authors:  Jiayun Yu; Li Yu; Yifei Li; Fan Hu
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

10.  Changes of Cell Biochemical States Are Revealed in Protein Homomeric Complex Dynamics.

Authors:  Bram Stynen; Diala Abd-Rabbo; Jacqueline Kowarzyk; Leonor Miller-Fleming; Simran Kaur Aulakh; Philippe Garneau; Markus Ralser; Stephen W Michnick
Journal:  Cell       Date:  2018-10-25       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.